原创力文档- 11
- 0
- 约10.65万字
- 约 53页
- 2020-12-08 发布于河南
- 举报
CENTER FOR DRUG EVALUATION AND
RESEARCH
APPLICATION NUMBER:
022271Orig1s000
LABELING
HIGHLIGHTS OF PRESCRIBING INFORMATION
WARNINGS AND PRECAUTIONS
These highlights do not include all the information needed to use
NESINA safely and effectively. See full prescribing information Acute pancreatitis: There have been postmarketing reports of
for NESINA.
文档评论（0）